Inactivated SARS-CoV-2 Vaccine clinical trials

Studies by the year they started

18 studies that test it; most in 2021 (10)

Who runs them

Industry 16 · Other 2

China National Biotec Group Company Limited (9) · Sinovac Research and Development Co., Ltd. (3) · Sinovac Life Sciences Co., Ltd. (2) · Jiangsu Province Centers for Disease Control and Prevention (1) · Laboratorio Elea Phoenix S.A. (1) · Sinovac Biotech (Colombia) S.A.S. (1) · Chinese Academy of Medical Sciences (1)

Studies

Open first, then newest update. How each study uses Inactivated SARS-CoV-2 Vaccine is read from its arms, and is right about nine times in ten.

Testing it · 18

• Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 VaccineCompletedPhase 3Jiangsu Province Centers for Disease Control and PreventionNCT05204589Written as Inactivated SARS-CoV-2 vaccine
• Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 VaccineActive, not recruitingPhase 4Sinovac Life Sciences Co., Ltd.NCT05329038Written as Inactivated COVID-19 Vaccine
• Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and AdolescentsCompletedPhase 3Sinovac Research and Development Co., Ltd.NCT04992260Written as Inactivated COVID-19 Vaccine
• Immunogenicity of an Inactivated COVID-19 VaccineCompletedPhase 4Sinovac Research and Development Co., Ltd.NCT05198336Written as Inactivated COVID-19 Vaccine
• Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and AboveActive, not recruitingPhase 3China National Biotec Group Company LimitedNCT05382871Written as COVID-19 Vaccine (Vero Cell), Inactivated
• Study on Sequential Immunization of Omicron Inactivated COVID-19 Vaccine and Prototype Inactivated COVID-19 Vaccine in Population Aged 18 Years Old and AboveActive, not recruitingPhase 3China National Biotec Group Company LimitedNCT05374954Written as COVID-19 Vaccine (Vero Cell), Inactivated
• A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and AboveCompletedPhase 3China National Biotec Group Company LimitedNCT04510207Written as Inactivated SARS-CoV-2 Vaccine (Vero cell)
• Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), InactivatedStatus unknownPhase 3Sinovac Biotech (Colombia) S.A.S.NCT05433272Written as COVID-19 Vaccine (Vero Cell), Inactivated
• Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the ElderlyCompletedPhase 4Sinovac Life Sciences Co., Ltd.NCT05398926Written as COVID-19 Vaccine (Vero cell), Inactivated
• Immunogenicity and Safety of an Inactivated COVID-19 VaccineCompletedPhase 4Sinovac Research and Development Co., Ltd.NCT04953325Written as Inactivated COVID-19 Vaccine
• Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)CompletedPhase 3Laboratorio Elea Phoenix S.A.NCT04560881Written as Inactivated SARS-CoV-2 vaccine (Vero cell)
• Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV InfectedStatus unknownPhase 4China National Biotec Group Company LimitedNCT05105295Written as Inactivated COVID-19 vaccine
• Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPDStatus unknownPhase 4China National Biotec Group Company LimitedNCT05104216Written as Inactivated COVID-19 vaccine
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPDStatus unknownPhase 4China National Biotec Group Company LimitedNCT05075057Written as Inactivated COVID-19 vaccine
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People Aged ≥18 Years With HIV InfectedStatus unknownPhase 4China National Biotec Group Company LimitedNCT05075044Written as Inactivated COVID-19 vaccine
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in People With HIV InfectedStatus unknownPhase 4China National Biotec Group Company LimitedNCT05075070Written as Inactivated COVID-19 vaccine
• Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPDStatus unknownPhase 4China National Biotec Group Company LimitedNCT05075083Written as Inactivated COVID-19 vaccine
• The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19Status unknownPhase 3Chinese Academy of Medical SciencesNCT04659239Written as Inactivated SARS-CoV-2 Vaccine (Vero cell)